2-(3-Aminobicyclo[1.1.1]pentan-1-yl)acetic acid hydrochloride, 98%, 500mg

2-(Hydroxymethyl)-1H-benzimidazole-1-propanoic acid, 97%, 250mg

(5-Bromopentyl)boronic acid, 95.0%, 1g

1-(2-piridilazo)-2-naftolo, minimo 98%, pa, ACS, 5 g, confezione in vetro

4,4,5,5-tetramethyl-2-(5-methyl-3-thienyl)-1,3,2-dioxaborolane, 95.0%, 5g

Cyanomethanesulfonyl chloride, 95.0%, 10g

2-(5-Fluoro-2-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

1-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 95.0%, 10g

Methyl4-bromo-3-chloro-5-(trifluoromethoxy)benzoate, 98%, 500mg

Simbolo di avvertenza secondo ISO 7010 Etichetta individuale, Rumore forte inatteso, Lunghezza lato 100 mm, 1 pezzo

Tetrakis(acetoxymethyl) 1,2-Bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetate>95.0%(HPLC)20mg

3-Bromo-a-methylbenzyl alcohol, 97.0%, 25g